109 related articles for article (PubMed ID: 25440726)
1. Non-anti-infective effects of antimicrobials and their clinical applications: a review.
Sadarangani SP; Estes LL; Steckelberg JM
Mayo Clin Proc; 2015 Jan; 90(1):109-27. PubMed ID: 25440726
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial agents, drug adverse reactions and interactions, and cancer.
Millan X; Muggia V; Ostrowsky B
Cancer Treat Res; 2014; 161():413-62. PubMed ID: 24706233
[TBL] [Abstract][Full Text] [Related]
3. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Use of macrolides and tetracyclines for chronic inflammatory diseases.
Voils SA; Evans ME; Lane MT; Schosser RH; Rapp RP
Ann Pharmacother; 2005 Jan; 39(1):86-94. PubMed ID: 15562139
[TBL] [Abstract][Full Text] [Related]
6. [Doxycycline or how to create new with the old?].
Shehwaro N; Langlois AL; Gueutin V; Gauthier M; Casenave M; Izzedine H
Therapie; 2014; 69(2):129-41. PubMed ID: 24926631
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
8. The genus Inula and their metabolites: from ethnopharmacological to medicinal uses.
Seca AM; Grigore A; Pinto DC; Silva AM
J Ethnopharmacol; 2014 Jun; 154(2):286-310. PubMed ID: 24754913
[TBL] [Abstract][Full Text] [Related]
9. Impact of different methods of feedback to clinicians after postprescription antimicrobial review based on the Centers For Disease Control and Prevention's 12 Steps to Prevent Antimicrobial Resistance Among Hospitalized Adults.
Cosgrove SE; Patel A; Song X; Miller RE; Speck K; Banowetz A; Hadler R; Sinkowitz-Cochran RL; Cardo DM; Srinivasan A
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):641-6. PubMed ID: 17520534
[TBL] [Abstract][Full Text] [Related]
10. Antibacterials as anti-inflammatory agents: dual action agents for oral health.
Sreenivasan PK; Gaffar A
Antonie Van Leeuwenhoek; 2008 Mar; 93(3):227-39. PubMed ID: 17851778
[TBL] [Abstract][Full Text] [Related]
11. Fourteen-membered ring macrolides as anti-angiogenic compounds.
Yatsunami J; Hayashi S
Anticancer Res; 2001; 21(6B):4253-8. PubMed ID: 11908678
[TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
13. Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs.
Powers JH
Clin Infect Dis; 2007 Sep; 45 Suppl 2():S153-62. PubMed ID: 17683020
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of bacterial resistance to tetracyclines in the treatment of periodontal diseases.
Greenstein G
J Periodontol; 1995 Nov; 66(11):925-32. PubMed ID: 8558393
[TBL] [Abstract][Full Text] [Related]
15. General principles of antimicrobial therapy.
Thompson RL; Wright AJ
Mayo Clin Proc; 1998 Oct; 73(10):995-1006. PubMed ID: 9787752
[TBL] [Abstract][Full Text] [Related]
16. Update of systemic antimicrobials: emphasis on oral agents.
Allen DM; Ling ML
Singapore Med J; 1994 Dec; 35(6):626-30. PubMed ID: 7761891
[TBL] [Abstract][Full Text] [Related]
17. Tetracyclines: nonantibiotic properties and their clinical implications.
Sapadin AN; Fleischmajer R
J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions with antibacterial agents.
Horn JR; Hansten PD
J Fam Pract; 1995 Jul; 41(1):81-90. PubMed ID: 7798069
[TBL] [Abstract][Full Text] [Related]
19. [Nonantibiotic properties of macrolides and their role in modulation of the inflammatory reaction].
Zupanets IA; Tkachenko EM; Sakharova TS
Eksp Klin Farmakol; 2012; 75(12):41-5. PubMed ID: 23700669
[TBL] [Abstract][Full Text] [Related]
20. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
Appelbaum PC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
